Cited 0 times in
Sildenafil and beraprost combination therapy in patients with pulmonary hypertension undergoing valvular heart surgery
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 곽영란 | - |
dc.contributor.author | 김소연 | - |
dc.contributor.author | 심연희 | - |
dc.contributor.author | 심재광 | - |
dc.date.accessioned | 2015-04-23T17:51:00Z | - |
dc.date.available | 2015-04-23T17:51:00Z | - |
dc.date.issued | 2010 | - |
dc.identifier.issn | 0966-8519 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/103253 | - |
dc.description.abstract | BACKGROUND AND AIM OF THE STUDY: Sildenafil and beraprost, as orally available pulmonary vasodilators, are used increasingly to treat pulmonary hypertension (PH). An evaluation was made, in patients with PH undergoing valvular heart surgery, as to whether preoperative combined oral sildenafil and beraprost treatment could induce synergistic and prolonged pulmonary vasodilation, or result in a loss of pulmonary selectivity. METHODS: Fifty patients scheduled for valvular heart surgery with a mean pulmonary arterial pressure (PAP) > 30 mmHg were randomly assigned to receive either 50 mg oral sildenafil + 40 microg beraprost, or a placebo, 15 min before the induction of anesthesia. Hemodynamic variables were measured intraoperatively. RESULTS: The treatment group had a significantly lower systemic vascular resistance index at 60 min after medication. No other significant intergroup differences in hemodynamic variables were observed. In addition, significantly more patients in the treatment group required vasopressor therapy. In both groups, the PAP was significantly reduced by general anesthesia, and almost normalized after valvular heart surgery. CONCLUSION: Preoperative oral sildenafil and beraprost treatment resulted in a loss of pulmonary selectivity, and did not provide any additional pulmonary vasodilation or favorable perioperative hemodynamics in patients with PH undergoing valvular heart surgery. | - |
dc.description.statementOfResponsibility | open | - |
dc.relation.isPartOf | JOURNAL OF HEART VALVE DISEASE | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/2.0/kr/ | - |
dc.subject.MESH | Adult | - |
dc.subject.MESH | Aged | - |
dc.subject.MESH | Anesthesia, General | - |
dc.subject.MESH | Blood Pressure/drug effects | - |
dc.subject.MESH | Comorbidity | - |
dc.subject.MESH | Drug Therapy, Combination | - |
dc.subject.MESH | Epoprostenol/administration & dosage | - |
dc.subject.MESH | Epoprostenol/analogs & derivatives* | - |
dc.subject.MESH | Epoprostenol/therapeutic use | - |
dc.subject.MESH | Female | - |
dc.subject.MESH | Heart Valve Diseases/epidemiology* | - |
dc.subject.MESH | Heart Valve Diseases/surgery* | - |
dc.subject.MESH | Hemodynamics | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Hypertension, Pulmonary/drug therapy* | - |
dc.subject.MESH | Hypertension, Pulmonary/epidemiology | - |
dc.subject.MESH | Hypertension, Pulmonary/physiopathology | - |
dc.subject.MESH | Male | - |
dc.subject.MESH | Middle Aged | - |
dc.subject.MESH | Piperazines/administration & dosage | - |
dc.subject.MESH | Piperazines/therapeutic use* | - |
dc.subject.MESH | Preoperative Care | - |
dc.subject.MESH | Purines/administration & dosage | - |
dc.subject.MESH | Purines/therapeutic use | - |
dc.subject.MESH | Sildenafil Citrate | - |
dc.subject.MESH | Sulfones/administration & dosage | - |
dc.subject.MESH | Sulfones/therapeutic use* | - |
dc.subject.MESH | Vascular Resistance/drug effects | - |
dc.subject.MESH | Vasoconstrictor Agents/therapeutic use | - |
dc.subject.MESH | Vasodilator Agents/administration & dosage | - |
dc.subject.MESH | Vasodilator Agents/therapeutic use* | - |
dc.title | Sildenafil and beraprost combination therapy in patients with pulmonary hypertension undergoing valvular heart surgery | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Anesthesiology (마취통증의학) | - |
dc.contributor.googleauthor | So Yeon Kim | - |
dc.contributor.googleauthor | Jae Kwang Shim | - |
dc.contributor.googleauthor | Yeon Hee Shim | - |
dc.contributor.googleauthor | Seong Wook Hong | - |
dc.contributor.googleauthor | Kil Hwan Choi | - |
dc.contributor.googleauthor | Young Lan Kwak | - |
dc.admin.author | false | - |
dc.admin.mapping | false | - |
dc.contributor.localId | A00172 | - |
dc.contributor.localId | A02196 | - |
dc.contributor.localId | A02205 | - |
dc.contributor.localId | A00616 | - |
dc.relation.journalcode | J01437 | - |
dc.identifier.eissn | 2053-2644 | - |
dc.identifier.pmid | 20583396 | - |
dc.contributor.alternativeName | Kwak, Young Lan | - |
dc.contributor.alternativeName | Kim, So Yeon | - |
dc.contributor.alternativeName | Shim, Yon Hee | - |
dc.contributor.alternativeName | Shim, Jae Kwang | - |
dc.contributor.affiliatedAuthor | Kwak, Young Lan | - |
dc.contributor.affiliatedAuthor | Shim, Yon Hee | - |
dc.contributor.affiliatedAuthor | Shim, Jae Kwang | - |
dc.contributor.affiliatedAuthor | Kim, So Yeon | - |
dc.citation.volume | 19 | - |
dc.citation.number | 3 | - |
dc.citation.startPage | 333 | - |
dc.citation.endPage | 340 | - |
dc.identifier.bibliographicCitation | JOURNAL OF HEART VALVE DISEASE, Vol.19(3) : 333-340, 2010 | - |
dc.identifier.rimsid | 37225 | - |
dc.type.rims | ART | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.